NAOV - Spark Newswire

2 minute read

News

NanoVibronix Says Ships First Order Of PainShield Plus; Says Expects To Recognize First Revenues From Product In Q3 2021

Today, 2:54 PM

NanoVibronix, Inc., (NASDAQ:NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave ("SAW") Portable Ultrasonic Therapeutic Devices, today announced it has

NAOV

2 minute read

Mid-Morning Market Update: Markets Mostly Lower; Lockheed Martin Posts Mixed Q2 Results

By Lisa Levin

Today, 2:54 PM

Following the market opening Monday, the Dow traded down 0.21% to 34,986.56 while the NASDAQ rose 0.06% to 14,845.70. The S&P also fell, dropping 0.09% to 4,407.92.

ATIP

9 minute read

Stocks That Hit 52-Week Highs On Monday

By Benzinga Insights

Today, 2:54 PM

This morning 121 companies reached new 52-week highs.

AAP

1 minute read

12 Health Care Stocks Moving In Monday’s Pre-Market Session

By Benzinga Insights

Today, 2:54 PM

ABEO

4 minute read

40 Stocks Moving in Monday’s Pre-Market Session

By Lisa Levin

Today, 2:54 PM

Gainers Dynatronics Corporation (NASDAQ: DYNT) shares rose 73.6% to $2.24 in pre-market trading after gaining over 9% on Friday.

ACOR

1 minute read

Why NanoVibronix (NAOV) Stock Is Trading Higher Monday?

By Vandana Singh

Today, 2:54 PM

The stock price of NanoVibronix Inc (NASDAQ: NAOV) closed 250% higher at $2.61 in very volatile and active afternoon trading Friday, and the stock is up almost 31% at $3.41 during the premarket on Monday.

NAOV

2 minute read

Movers

12 Health Care Stocks Moving In Friday’s After-Market Session

By Benzinga Insights

Today, 2:54 PM

Gainers

ACOR

1 minute read

Legal
News

NanoVibronix Gets Australian Therapeutic Goods Administration Approval For Co’s UroShield system

By Benzinga Newsdesk

Today, 2:54 PM

https://www.ebs.tga.gov.au/servlet/xmlmillr6?dbid=ebs/PublicHTML/pdfStore.nsf&docid=A45A1D41788FC121CA25871A004226A5&agid=(PrintDetailsPublic)

NAOV

3 minute read

38 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

Today, 2:54 PM

Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares jumped 218.7% to $6.57 after the company received a $28.3 million purchase order from Brazil's Bio-Manguinhos to purchase Chembio's DPP SARS-CoV-2 Antigen tests for delivery during 2021.

AFI

1 minute read

12 Health Care Stocks Moving In Wednesday’s Pre-Market Session

By Benzinga Insights

Today, 2:54 PM

Gainers Chembio Diagnostics (NASDAQ: CEMI) shares rose 102.91% to $4.18 during Wednesday's pre-market session. The market value of their outstanding shares is at $84.6 million. Lexaria Bioscience (NASDAQ: LEXX) sharesGainers

AFIB

Feed Symbols: NAOV